| Bayshore Pharmacy | |
| 2 Bayshore Plz, Atlantic Highlands, New Jersey 07716 | |
| (732) 291-2900 |
| Name | Bayshore Pharmacy |
|---|---|
| Organization Name | Seabright Pharmacy Inc |
| Location | 2 Bayshore Plz, Atlantic Highlands, New Jersey 07716 |
| Type | Pharmacy |
| Phone | (732) 291-2900 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Guidant Corporation has received Conformité Européenne (CE) Mark approval to launch its CONTAK RENEWAL 4 cardiac resynchronization therapy defibrillators for use outside the United States.
Before 2001, catastrophic craniovertebral junction (CVJ) injuries were the most common cause of death to drivers in the fast-paced sport of professional car racing. That changed with the development and implementation of the HANS (Head and Neck Support) device and similar restraints.
Researchers at McMaster University have found that brief high intensity workouts, as little as six sessions over two weeks, rapidly lower blood sugar levels in type 2 diabetics, offering a potential fix for patients who struggle to meet exercise guidelines.
Pathogenic listeria tricks intestinal cells into helping it pass through those cells to make people ill, and, if that doesn't work, the bacteria simply goes around the cells, according to a Purdue University study.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the United States Patent & Trademark Office has issued U.S. Patent No. 8,034,829 to Rexahn, entitled "5, 6, or 7-Substituted-3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof."
› Verified 2 days ago
| NPI Number | 1225028293 |
| Organization Name | SEABRIGHT PHARMACY INC |
| Doing Business As | BAYSHORE PHARMACY |
| Type | Pharmacy |
| Address | 2 Bayshore Plz, Atlantic Highlands, NJ 07716 |
| Phone Number | 732-291-2900 |
News Archive
Guidant Corporation has received Conformité Européenne (CE) Mark approval to launch its CONTAK RENEWAL 4 cardiac resynchronization therapy defibrillators for use outside the United States.
Before 2001, catastrophic craniovertebral junction (CVJ) injuries were the most common cause of death to drivers in the fast-paced sport of professional car racing. That changed with the development and implementation of the HANS (Head and Neck Support) device and similar restraints.
Researchers at McMaster University have found that brief high intensity workouts, as little as six sessions over two weeks, rapidly lower blood sugar levels in type 2 diabetics, offering a potential fix for patients who struggle to meet exercise guidelines.
Pathogenic listeria tricks intestinal cells into helping it pass through those cells to make people ill, and, if that doesn't work, the bacteria simply goes around the cells, according to a Purdue University study.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the United States Patent & Trademark Office has issued U.S. Patent No. 8,034,829 to Rexahn, entitled "5, 6, or 7-Substituted-3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof."
› Verified 2 days ago
News Archive
Guidant Corporation has received Conformité Européenne (CE) Mark approval to launch its CONTAK RENEWAL 4 cardiac resynchronization therapy defibrillators for use outside the United States.
Before 2001, catastrophic craniovertebral junction (CVJ) injuries were the most common cause of death to drivers in the fast-paced sport of professional car racing. That changed with the development and implementation of the HANS (Head and Neck Support) device and similar restraints.
Researchers at McMaster University have found that brief high intensity workouts, as little as six sessions over two weeks, rapidly lower blood sugar levels in type 2 diabetics, offering a potential fix for patients who struggle to meet exercise guidelines.
Pathogenic listeria tricks intestinal cells into helping it pass through those cells to make people ill, and, if that doesn't work, the bacteria simply goes around the cells, according to a Purdue University study.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the United States Patent & Trademark Office has issued U.S. Patent No. 8,034,829 to Rexahn, entitled "5, 6, or 7-Substituted-3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof."
› Verified 2 days ago
Bayshore Pharmacy Type: Pharmacy Location: 2 Bayshore Plz, Atlantic Highlands, New Jersey 07716 Phone: (732) 291-2900 |